Micrometastases in apheresis products predict shorter progression-free and overall survival in patients with breast cancer undergoing high-dose chemotherapy (HDCT) and autologous blood stem cell transplantation (ABSCT)

R. Syme, D. Stewart, M. Rodriguez-Galvez, J. Luider, Y. Auer, J. Klassen, D. Morris, C. Brown, J. Russell, S. Glück

Research output: Contribution to journalArticlepeer-review

13 Scopus citations

Fingerprint Dive into the research topics of 'Micrometastases in apheresis products predict shorter progression-free and overall survival in patients with breast cancer undergoing high-dose chemotherapy (HDCT) and autologous blood stem cell transplantation (ABSCT)'. Together they form a unique fingerprint.

Medicine & Life Sciences